-+ 0.00%
-+ 0.00%
-+ 0.00%

Legend Biotech To Present Six Poster Presentations Featuring Data On CARVYKTI At Tandem Meetings Of ASTCT And CIBMTR

Benzinga·01/21/2026 13:10:16
Listen to the news

Six poster presentations highlight CARVYKTI® efficacy, safety, and real-world outcomes across CARTITUDE trials and analyses, reflecting a maturing and expanding body of evidence

SOMERSET, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ:LEGN) (Legend Biotech), a global leader in cell therapy, will present six poster presentations featuring data on CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) at the Tandem Meetings of ASTCT® and CIBMTR®, taking place February 4-7, 2026, in Salt Lake City, UT.